Drug Profile
Elcometrine - Acrux
Alternative Names: Elcometrine MDTS®; Elcometrine spray - Acrux; Elcometrine transdermal spray - Acrux; Nestorone MDTSLatest Information Update: 14 Feb 2007
Price :
$50
*
At a glance
- Originator Population Council (USA)
- Class Hormonal contraceptives; Norpregnenes; Pregnenediones; Small molecules
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Menopausal syndrome; Pregnancy
Most Recent Events
- 10 Aug 2006 Acrux and the Population Council have amended the existing licensing agreement
- 13 Feb 2006 This product has been licensed to Acrux worldwide; the company intends to seek commercial partners for further product development and global commercialisation
- 30 Jun 2005 Phase I findings have been added to the adverse events and Women's Health pharmacodynamics sections